Methoxylation of desazadesferrithiocin analogues: enhanced iron clearing efficiency
- PMID: 12672247
- DOI: 10.1021/jm020412d
Methoxylation of desazadesferrithiocin analogues: enhanced iron clearing efficiency
Abstract
The impact of altering the octanol-water partition properties (log P) of analogues of desazadesferrithiocin, (S)-4,5-dihydro-2-(2-hydroxyphenyl)-4-methyl-4-thiazolecarboxylic acid, on the ligands' iron clearing properties is described. Increasing chelator lipophilicity can both substantially augment iron clearing efficiency in Cebus apella primates as well as alter the mode of iron excretion, favoring fecal over urinary output. The complications of iron overload are often associated with the metal's interaction with hydrogen peroxide, generating hydroxyl radicals (Fenton chemistry) and, ultimately, other related deleterious species. In fact, some iron chelators actually promote this chemistry. All of the compounds synthesized and tested in the current study are shown to be both inhibitors of the iron-mediated oxidation of ascorbate, thus removing the metal from the Fenton cycle, and effective radical scavengers.
Similar articles
-
Partition-variant desferrithiocin analogues: organ targeting and increased iron clearance.J Med Chem. 2005 Feb 10;48(3):821-31. doi: 10.1021/jm049306x. J Med Chem. 2005. PMID: 15689166
-
Desferrithiocin analogue based hexacoordinate iron(III) chelators.J Med Chem. 2003 Jan 2;46(1):16-24. doi: 10.1021/jm020184n. J Med Chem. 2003. PMID: 12502356
-
Effects of C-4 stereochemistry and C-4' hydroxylation on the iron clearing efficiency and toxicity of desferrithiocin analogues.J Med Chem. 1999 Jul 1;42(13):2432-40. doi: 10.1021/jm990058s. J Med Chem. 1999. PMID: 10395484
-
Structure-activity relationships among desazadesferrithiocin analogues.Adv Exp Med Biol. 2002;509:167-84. doi: 10.1007/978-1-4615-0593-8_9. Adv Exp Med Biol. 2002. PMID: 12572994 Review.
-
Iron chelators for clinical use.Met Ions Biol Syst. 1998;35:691-730. Met Ions Biol Syst. 1998. PMID: 9444773 Review. No abstract available.
Cited by
-
Desferrithiocin: a search for clinically effective iron chelators.J Med Chem. 2014 Nov 26;57(22):9259-91. doi: 10.1021/jm500828f. Epub 2014 Sep 10. J Med Chem. 2014. PMID: 25207964 Free PMC article. Review.
-
Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicity.Biometals. 2011 Apr;24(2):239-58. doi: 10.1007/s10534-010-9389-y. Epub 2010 Nov 20. Biometals. 2011. PMID: 21103911 Free PMC article.
-
The impact of polyether chain length on the iron clearing efficiency and physiochemical properties of desferrithiocin analogues.J Med Chem. 2010 Apr 8;53(7):2843-53. doi: 10.1021/jm9018146. J Med Chem. 2010. PMID: 20232803 Free PMC article.
-
Impact of the 3,6,9-trioxadecyloxy group on desazadesferrithiocin analogue iron clearance and organ distribution.J Med Chem. 2007 Jul 12;50(14):3302-13. doi: 10.1021/jm070214s. Epub 2007 Jun 12. J Med Chem. 2007. PMID: 17564424 Free PMC article.
-
Deferoxamine to Minimize Fibrosis During Radiation Therapy.Adv Wound Care (New Rochelle). 2022 Oct;11(10):548-559. doi: 10.1089/wound.2021.0021. Epub 2021 Jul 26. Adv Wound Care (New Rochelle). 2022. PMID: 34074152 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources